Physician
Siclari, Michael
Siclari, Michael was paid $93K by Medicaid between Nov 2020 and Sep 2024, across 14 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoSICLARI, MICHAEL
PAWTUCKET, RI 02860
PAWTUCKET, RI 02860
33aNPI1033226444assigned 08/23/2006
33bProvider typeEmergency Medicine Physician
28Total paid$93K
24GClaims1,127
24DCodes billed14
24AFirst – last monthNov 2020 – Sep 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Rhode Island
Rank by total paid#98 of 188
Median peer was paid$94K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 32 | $1K | |
| 2022 | 96 | $12K | |
| 2023 | 589 | $47K | |
| 2024incomplete | 410 | $33K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 443 | 428 | $30K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 20% | 139 | 135 | $18K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 17% | 82 | 75 | $16K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.0% | 161 | 154 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.1% | 29 | 28 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.1% | 55 | 50 | $5K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.3% | 32 | 25 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.9% | 27 | 26 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.1% | 27 | 26 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 15 | 14 | $591.32 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 49 | 48 | $476.69 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13 | 13 | $264.91 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.